Cargando…
Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier
Disruption of blood–brain barrier (BBB) integrity is a feature of various neurological disorders. Here we found that the BBB is differently affected during the preclinical, progression and remission phase of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS)....
Autores principales: | Zeitelhofer, Manuel, Adzemovic, Milena Z., Moessinger, Christine, Stefanitsch, Christina, Strell, Carina, Muhl, Lars, Brundin, Lou, Fredriksson, Linda, Olsson, Tomas, Eriksson, Ulf, Nilsson, Ingrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759579/ https://www.ncbi.nlm.nih.gov/pubmed/33361796 http://dx.doi.org/10.1038/s41598-020-79598-z |
Ejemplares similares
-
Preclinical toxicological assessment of a novel monoclonal antibody targeting human platelet-derived growth factor CC (PDGF-CC) in PDGF-CC(hum) mice
por: Zeitelhofer, Manuel, et al.
Publicado: (2018) -
Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response
por: Z. Adzemovic, Milena, et al.
Publicado: (2013) -
Correction: Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response
por: Z. Adzemovic, Milena, et al.
Publicado: (2013) -
Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke
por: Su, Enming Joseph, et al.
Publicado: (2017) -
Development of monoclonal anti-PDGF-CC antibodies as tools for investigating human tissue expression and for blocking PDGF-CC induced PDGFRα signalling in vivo
por: Li, Hong, et al.
Publicado: (2018)